Antares Pharma, Inc.

Bank of New York Mellon Corp MJC

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/11/2022

Shares

736,241

Value ($000)

3,019

Weight

0.0%

2013 Q4 - 2022 Q1 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/11/2022	3,019	0.0%	736,241	3/31/2022
2021 Q4	2/11/2022	2,567	0.0%	719,090	12/31/2021
2021 Q3	11/18/2021	2,168	0.0%	595,828	9/30/2021
2021 Q2	8/11/2021	2,490	0.0%	571,041	6/30/2021
2021 Q1	5/13/2021	2,781	0.0%	676,705	3/31/2021
2020 Q4	2/9/2021	2,759	0.0%	691,333	12/31/2020
2020 Q3	11/12/2020	1,747	0.0%	646,924	9/30/2020
2020 Q2	8/12/2020	1,783	0.0%	648,545	6/30/2020
2020 Q1	5/6/2020	1,485	0.0%	629,369	3/31/2020
2019 Q4	2/14/2020	3,789	0.0%	806,219	12/31/2019
2014 Q1	5/14/2014	3,230	0.0%	922,742	3/31/2014
2013 Q4	2/12/2014	3,682	0.0%	823,763	12/31/2013